Heron Therapeutics (AXD2.F) Q4 2024 Earnings

Nov 12Confirmed
Q4 2023
Q2 2024
Q3 2024
Q4 2024
-0.14
-0.1
-0.06
-0.02

Details

Expected EPS
-0.03567635625
Actual EPS
-0.0282585
Surprise EPS
0.01
Surprise Percent
+20.79%

Description

⁨Heron Therapeutics⁩ (⁦AXD2.F⁩) has reported earnings of ⁦-0.0282585⁩ per share for ⁦Q4 2024⁩.

0 Comments

Share your thoughts